We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

2357:TWSEASUSTeK Computer Inc. Analysis

Data as of 2026-06-11 - not real-time

NT$784.00

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

ASUSTeK Computer Inc. is trading at TWD 784, comfortably above its 20‑day SMA of 760.6 and well above the 50‑day (664.24) and 200‑day (616.64) averages, indicating a bullish price bias. The stock’s PE ratio of 13.2 is dramatically lower than the industry average of 36.5, while the dividend yield sits at a robust 4.34% with a payout ratio of 57%, suggesting attractive income potential. Recent earnings showed a 44% YoY revenue surge to TWD 194 billion and a 30% jump in operating profit, prompting management to raise full‑year guidance, which underpins the upside momentum.


However, the fundamentals reveal friction points: operating cash flow and free cash flow are negative, the debt‑to‑equity ratio is high at 13.7, and 30‑day volatility is elevated at 67%, reflecting a risk‑laden environment. Technical indicators are mixed—RSI is neutral at 54.8 but the MACD histogram is negative, signaling short‑term bearish pressure. Overall, the stock appears undervalued with strong growth catalysts, yet cash‑flow weakness and high leverage temper confidence.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Price above key moving averages supporting bullish bias
  • Negative MACD histogram indicating near‑term downside pressure
  • High short‑term volatility (67% 30‑day) raising uncertainty

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • Strong revenue growth (41% YoY) and raised guidance
  • Significant valuation discount vs industry PE
  • Attractive dividend yield despite cash‑flow concerns

Long Term

> 3 years
Positive
Model confidence: 8/10

Key Factors

  • Sustained earnings growth and market leadership in computer hardware
  • Undervalued multiples combined with a solid dividend yield
  • Improving operating profitability (operating margin 5.7%) offsetting cash‑flow deficits

Key Metrics & Analysis

Financial Health

Revenue Growth41.10%
Profit Margin5.20%
P/E Ratio13.2
ROE14.57%
ROA3.89%
Debt/Equity13.72
P/B Ratio2.0
Op. Cash FlowNT$-29472077824
Free Cash FlowNT$-40083124224
Industry P/E36.5

Technical Analysis

TrendBullish
RSI54.8
SupportNT$622.00
ResistanceNT$964.00
MA 20NT$760.60
MA 50NT$664.24
MA 200NT$616.64
MACDBearish
VolumeIncreasing
Fear & Greed Index86.71

Valuation

Target PriceNT$785.70
Upside/Downside0.22%
GradeUndervalued
TypeBlend
Dividend Yield4.34%

Risk Assessment

Beta0.77
Volatility67.04%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.